Get started
ALPS Medical Breakthroughs ETFALPS Medical Breakthroughs ETFALPS Medical Breakthroughs ETF

ALPS Medical Breakthroughs ETF

No trades
See on Supercharts
Overview Analysis
Holdings
News Ideas Discussions Technicals Seasonals Options

ALPS Medical Breakthroughs ETF holdings


As of July 3, 2025
Symbol
Weight %
Shares
Market value
N
NUVLNuvalent, Inc. Class A
3.51%
‪‪32.74 K‬‬
‪‪2.63 M‬‬USD
A
AXSMAxsome Therapeutics, Inc.
3.41%
‪‪24.28 K‬‬
‪‪2.56 M‬‬USD
A
ALKSAlkermes Public Limited Company
3.13%
‪‪81.36 K‬‬
‪‪2.35 M‬‬USD
P
PCVXVaxcyte, Inc.
2.82%
‪‪63.71 K‬‬
‪‪2.12 M‬‬USD
R
RYTMRhythm Pharmaceuticals, Inc.
2.74%
‪‪31.26 K‬‬
‪‪2.06 M‬‬USD
C
CYTKCytokinetics, Incorporated
2.72%
‪‪58.92 K‬‬
‪‪2.04 M‬‬USD
A
AKROAkero Therapeutics, Inc.
2.71%
‪‪39.27 K‬‬
‪‪2.03 M‬‬USD
K
KRYSKrystal Biotech, Inc.
2.71%
‪‪14.20 K‬‬
‪‪2.03 M‬‬USD
Z
ZLABZai Lab Ltd. Sponsored ADR
2.70%
‪‪55.64 K‬‬
‪‪2.03 M‬‬USD
M
MRUSMerus N.V.
2.63%
‪‪36.71 K‬‬
‪‪1.98 M‬‬USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.